Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
J Neuroimmunol
; 361: 577755, 2021 12 15.
Article
Dans Anglais
| MEDLINE | ID: covidwho-1472063
ABSTRACT
Vaccine administration may be involved in the development of some central nervous system demyelinating diseases. The COVID-19 vaccine is being administered to the entire population, but to date, little association between vaccination and the risk of developing multiple sclerosis (MS) has been suggested, and only a few case reports have been published. Here, we present a 40-year-old woman who developed cervical myelitis after receiving the COVID-19 vaccine. Myelitis was considered the initial clinical manifestation of MS. Our case suggests a possible link between the vaccination and the clinical MS attack.
Mots clés
Texte intégral:
Disponible
Collection:
Bases de données internationales
Base de données:
MEDLINE
Sujet Principal:
COVID-19
/
Vaccin BNT162
/
Sclérose en plaques
Type d'étude:
Rapport de cas
/
Étude observationnelle
/
Étude pronostique
Les sujets:
Covid long
/
Vaccins
Limites du sujet:
Adulte
/
Femelle
/
Humains
langue:
Anglais
Revue:
J Neuroimmunol
Année:
2021
Type de document:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS